- Home
- CDLX vs NPCE Comparison
CDLX vs NPCE Comparison
Compare CDLX & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLX
- NPCE
- Stock Information
- Founded
- CDLX 2008
- NPCE 1997
- Country
- CDLX United States
- NPCE United States
- Employees
- CDLX N/A
- NPCE N/A
- Industry
- CDLX Computer Software: Programming Data Processing
- NPCE Medical Specialities
- Sector
- CDLX Technology
- NPCE Health Care
- Exchange
- CDLX Nasdaq
- NPCE Nasdaq
- Market Cap
- CDLX 190.9M
- NPCE 217.5M
- IPO Year
- CDLX 2018
- NPCE 2021
- Fundamental
- Price
- CDLX $4.37
- NPCE $7.51
- Analyst Decision
- CDLX Hold
- NPCE Buy
- Analyst Count
- CDLX 6
- NPCE 7
- Target Price
- CDLX $5.90
- NPCE $16.00
- AVG Volume (30 Days)
- CDLX 879.4K
- NPCE 80.2K
- Earning Date
- CDLX 11-06-2024
- NPCE 11-12-2024
- Dividend Yield
- CDLX N/A
- NPCE N/A
- EPS Growth
- CDLX N/A
- NPCE N/A
- EPS
- CDLX N/A
- NPCE N/A
- Revenue
- CDLX $293,468,000.00
- NPCE $71,819,000.00
- Revenue This Year
- CDLX N/A
- NPCE $20.21
- Revenue Next Year
- CDLX $8.09
- NPCE $15.04
- P/E Ratio
- CDLX N/A
- NPCE N/A
- Revenue Growth
- CDLX N/A
- NPCE 30.75
- 52 Week Low
- CDLX $2.89
- NPCE $5.45
- 52 Week High
- CDLX $20.52
- NPCE $18.15
- Technical
- Relative Strength Index (RSI)
- CDLX 55.14
- NPCE 61.75
- Support Level
- CDLX $3.53
- NPCE $6.03
- Resistance Level
- CDLX $5.25
- NPCE $7.91
- Average True Range (ATR)
- CDLX 0.35
- NPCE 0.56
- MACD
- CDLX 0.05
- NPCE 0.17
- Stochastic Oscillator
- CDLX 48.98
- NPCE 83.67
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.